- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04937127
Efficiency of E-learning and Role-playing for the Training of Nursing Home Caregivers in the Support of Agitation in Neurodegenerative Diseases
Efficacité du E-learning et du Jeu de rôle Pour la Formation Des Soignants Des EHPAD à l'Accompagnement de l'Agitation Dans Les Maladies neurodégénératives : Essai randomisé en Cluster
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Châteaugiron, France, 35000
- EHPAD Résidence du Prévot
-
Liffré, France, 35340
- Maison Saint Michel
-
Montlouis-sur-Loire, France, 37270
- EHPAD La Bourdaisière
-
Pléchâtel, France, 35470
- Résidence Père Brottier
-
Rochecorbon, France, 37210
- EHPAD Le Clos Saint-Vincent
-
Tours, France, 37012
- EHPAD Montconseil
-
Tours, France, 37100
- EHPAD La Source
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Diagnosis of Major Neurocognitive Disorder according to DSM 5
- With agitation and NPI agitation item score of 4 or more (frequency X severity)
- Information and verification of the non-opposition of the patient and his guardian / curator if he is under legal protection.
Exclusion Criteria:
- Patient under court protection
- Inability to understand the French language
- Patient whose state of health is not stabilised at the time of inclusion and/or in palliative care
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Experimental Group
The experimental group will be made up of patients from nursing homes whose carers have received I-Learn training.
|
Training of psycho-behavorial disorders care in neurodegenerative diseases: including a theoretical part in e-learning and a practical part
usual care
|
Control Group
The control group will consist of nursing homes patients whose caregivers have not received I-Learn training and will continue their usual care, regardless of the practices already implemented.
|
usual care
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Measurement of agitation of patients in the nursing home
Time Frame: Baseline
|
Assessment of agitation using the Cohen-Mansfield Agitation Inventory (CMAI, 1989) by asking caregivers about the patients' behaviour. The minimum value is 0 and the maximum value is 203. the higher the score, the more intense the agitation |
Baseline
|
Measurement of agitation of patients in the nursing home
Time Frame: 3 months
|
Assessment of agitation using the Cohen-Mansfield Agitation Inventory (CMAI, 1989) by asking caregivers about the patients' behaviour. The minimum value is 0 and the maximum value is 203. the higher the score, the more intense the agitation |
3 months
|
Measurement of agitation of patients in the nursing home
Time Frame: 6 months
|
Assessment of agitation using the Cohen-Mansfield Agitation Inventory (CMAI, 1989) by asking caregivers about the patients' behaviour. The minimum value is 0 and the maximum value is 203. the higher the score, the more intense the agitation |
6 months
|
Measurement of agitation of patients in the nursing home
Time Frame: 9 months
|
Assessment of agitation using the Cohen-Mansfield Agitation Inventory (CMAI, 1989) by asking caregivers about the patients' behaviour. The minimum value is 0 and the maximum value is 203. the higher the score, the more intense the agitation |
9 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Frequency and severity of Psychobehavioural Symptoms associated with Dementia
Time Frame: Baseline, 3 months, 6 months and 9 months
|
Assessment using the Neuro Psychiatric Inventory, care team version (NPI-ES, 2000).
10 behavioural domains and 2 neurovegetative variables are considered.
item score = frequency x severity frequency minimum = 1 and maximum = 4 severity minimum = 1 and maximum = 3 A score above 2 is pathological
|
Baseline, 3 months, 6 months and 9 months
|
Quality of life of patients
Time Frame: Baseline, 3 months, 6 months and 9 months
|
Assessment using the Quality of Life-Alzheimer's Disease (QOL-AD, 2009) 13 questions focus on the patient's quality of life.
the patient's current quality of life in each domain is assessed by choosing one of the following four words: poor, fair, good, excellent.
|
Baseline, 3 months, 6 months and 9 months
|
Impact of I-Learn on psychotropic drug prescriptions
Time Frame: Baseline, 3 months, 6 months and 9 months
|
Changes in the prescriptions given to patients in terms of psychotropic drugs (addition or withdrawal of a neuroleptic, antidepressant, anxiolytic, etc.)
|
Baseline, 3 months, 6 months and 9 months
|
Impact of I-Learn on psychotropic drug prescriptions
Time Frame: Baseline, 3 months, 6 months and 9 months
|
Changes in the prescriptions given to patients in terms of dosage (increase/decrease of the daily dose)
|
Baseline, 3 months, 6 months and 9 months
|
Impact of I-Learn training on hospital admissions
Time Frame: 3 months, 6 months and 9 months
|
number of transfers to acute or emergency departments
|
3 months, 6 months and 9 months
|
Impact of I-Learn training on hospital admissions
Time Frame: 3 months, 6 months and 9 months
|
reasons for hospitalisation
|
3 months, 6 months and 9 months
|
Impact of Psychobehavioural Symptoms Associated with Dementia on the professional practice of health care teams
Time Frame: Baseline, 3 months, 6 months and 9 months
|
Assessment using the Neuro Psychiatric Inventory, care team version (NPI-ES, 2000) 10 behavioural domains and 2 neurovegetative variables are considered.
item score = frequency x severity fequency minimum = 1 and maximum = 4 severity minimum = 1 and maximum = 3 A score above 2 is pathological
|
Baseline, 3 months, 6 months and 9 months
|
Caregiver burnout at work
Time Frame: Baseline, 6 months and 9 months
|
Assessment using the Maslach Burnout Inventory (MBI, 1986) 22 items For each item, the minimum value is 0 and the maximum value is 6 BURNOUT Questions 1.2.3.6.8.13.14.16.20 Degree of burn out Total below 17 = low Total between 18 and 29 = moderate Total above 30 = high DEPERSONALISATION Questions 5.10.11.15.22 Degree of burn out Total below 5 = low Total between 6 and 11 = moderate Total above 12 = high PERSONAL FULFILMENT Questions 4.7.9.12.17.18.19.21 Degree of burn out Total above 40 = low Total between 34 and 39 = moderate Total below 33 = high Moderate or even high scores are a sign of latent burnout that is taking hold. |
Baseline, 6 months and 9 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Céline LOURDEL, University Hospital, Tours
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- DR200087 (I-LEARN)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Neuro-Degenerative Disease
-
Xuanwu Hospital, BeijingCompletedNeuro-Degenerative Disease
-
University Health Network, TorontoRecruiting
-
Weill Medical College of Cornell UniversityCompletedNeuro-Degenerative DiseaseUnited States
-
University Health Network, TorontoRecruiting
-
IRCCS San RaffaeleCompleted
-
Chinese University of Hong KongEnrolling by invitationNeuro-Degenerative DiseaseHong Kong
-
University Hospital, BordeauxUnknown
-
Weill Medical College of Cornell UniversityTerminatedCancer | Neuro-Degenerative DiseaseUnited States
-
Neuromed IRCCSCompletedCardiovascular Diseases | Cancer | Pregnancy | Neuro-Degenerative DiseaseItaly
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaUniversity of BolognaUnknownGlaucoma | Neuro-Degenerative DiseaseItaly
Clinical Trials on I-LEARN training
-
Vastra Gotaland RegionCompletedMigraine Without Aura | Migraine With AuraSweden
-
Holland Bloorview Kids Rehabilitation HospitalCompleted
-
Vastra Gotaland RegionNot yet recruiting
-
Herlev HospitalNot yet recruitingMelanoma | Pigmented Lesions
-
Herlev HospitalEnrolling by invitation
-
Herlev HospitalCompleted
-
Vastra Gotaland RegionGöteborg UniversityActive, not recruiting
-
University of North Carolina, Chapel HillCompleted
-
University of South FloridaCompletedMild Cognitive Impairment | Age-related Cognitive DeclineUnited States